Page last updated: 2024-10-29

staurosporine aglycone and Bone Cancer

staurosporine aglycone has been researched along with Bone Cancer in 1 studies

staurosporine aglycone: metabolite from culture broth of Nocardiopsis sp.; a neurotrophin antag; inhibits BDNF TrkB receptor

Research Excerpts

ExcerptRelevanceReference
"Chondrosarcoma is the primary malignancy of bone that is characterized by a potent capacity to invade locally and cause distant metastasis, and is therefore associated with poor prognoses."1.39Apoptosis signal-regulating kinase 1 is involved in brain-derived neurotrophic factor (BDNF)-enhanced cell motility and matrix metalloproteinase 1 expression in human chondrosarcoma cells. ( Chang, SL; Fong, YC; Hsu, CJ; Lin, CY; Tang, CH, 2013)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lin, CY1
Chang, SL1
Fong, YC1
Hsu, CJ1
Tang, CH1

Other Studies

1 other study available for staurosporine aglycone and Bone Cancer

ArticleYear
Apoptosis signal-regulating kinase 1 is involved in brain-derived neurotrophic factor (BDNF)-enhanced cell motility and matrix metalloproteinase 1 expression in human chondrosarcoma cells.
    International journal of molecular sciences, 2013, Jul-25, Volume: 14, Issue:8

    Topics: Anthracenes; Bone Neoplasms; Brain-Derived Neurotrophic Factor; Carbazoles; Cell Line, Tumor; Cell M

2013